180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF
· Real-Time Price · USD
7.09
-0.52 (-6.83%)
At close: Aug 15, 2025, 3:59 PM
180 Life Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 95.11K | 95.11K | 95.11K | 166.03K | 166.03K | 166.03K | 166.03K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 61.41K | 85.39K | 108.97K | 144.42K | 163.26K | 167.83K | 166.03K | 120.62K | 95.9K | 104.31K | 109K | 94.55K | 121.53K | 114.09K | 116.3K | 93.14K | 89.37K | 59.85K |
Gross Profit | 33.71K | 9.72K | -13.85K | 21.61K | 2.77K | -1.8K | n/a | -120.62K | -95.9K | -104.31K | -109K | -94.55K | -121.53K | -114.09K | -116.3K | -93.14K | -89.37K | -59.85K |
Operating Income | -6.49M | -6.61M | -6.32M | -6.37M | -8.93M | -10.77M | -13.48M | -17.66M | -18.18M | -19.02M | -17.9M | -16.72M | -16.88M | -16.37M | -15.64M | -13.59M | -10.11M | -7.03M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.56K | 4.56K | 4.56K | 4.56K | n/a | 613.81K | 719.89K | 914.21K |
Pretax Income | -9.5M | -7.76M | -6.46M | -3.13M | -14.9M | -18.59M | -22.28M | -43.74M | -52.61M | -45.99M | -39.67M | -15.95M | 23.82M | -2.58M | -20.35M | -29.32M | -48.45M | -24.72M |
Net Income | -9.21M | -7.47M | -6.17M | -3.12M | -12.55M | -16.24M | -19.94M | -40.45M | -51.67M | -45.05M | -38.73M | -15.95M | 23.84M | -2.56M | -20.32M | -29.3M | -48.43M | -24.7M |
Selling & General & Admin | 4.98M | 4.8M | 4.33M | 4.82M | 6.68M | 8.22M | 10.69M | 14.26M | 15.24M | 16.5M | 15.47M | 12.9M | 13.09M | 12.09M | 11.69M | 10.76M | 7.39M | 4.87M |
Research & Development | 1.23M | 1.67M | 1.97M | 1.6M | 2.3M | 2.6M | 2.86M | 3.41M | 2.94M | 2.52M | 2.43M | 3.82M | 3.8M | 4.29M | 3.95M | 2.84M | 2.72M | 2.16M |
Other Expenses | 275.83K | 135.46K | n/a | -72.72K | -72.72K | -87.14K | -87.14K | -14.42K | -14.42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.6K | -2.6K |
Operating Expenses | 6.49M | 6.61M | 6.3M | 6.35M | 8.91M | 10.73M | 13.46M | 17.65M | 18.17M | 19.02M | 17.9M | 16.72M | 16.88M | 16.37M | 15.64M | 13.59M | 10.11M | 7.03M |
Interest Expense | 17.5K | 31.54K | 50.64K | 51.47K | 49.48K | 49.72K | 44.83K | 39.35K | 36.6K | 33.88K | 29.73K | 38.48K | 49.25K | 66.74K | 186.21K | 786.73K | 873.15K | 1.04M |
Selling & Marketing Expenses | n/a | n/a | -23.58K | -23.58K | -23.58K | -23.58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 379.00 | 16.58K | 21.25K |
Cost & Expenses | 6.49M | 6.61M | 6.32M | 6.37M | 8.93M | 10.75M | 13.46M | 17.65M | 18.17M | 19.02M | 17.9M | 16.72M | 16.88M | 16.37M | 15.64M | 13.59M | 10.11M | 7.03M |
Income Tax Expense | -296.02K | -296.02K | -296.02K | -4.39K | -2.35M | -2.35M | -2.35M | -1.4M | 942.75K | 942.75K | 942.75K | 6.62K | 12.23K | 17.8K | 23.2K | 21.84K | 21.36K | 20.73K |
Shares Outstanding (Basic) | 5.71M | 3.54M | 980.64K | 980.64K | 919.14K | 638.34K | 622K | 418K | 275K | 197.22K | 117K | 103K | 89K | 89K | 90K | 88.71K | 82K | 73K |
Shares Outstanding (Diluted) | 5.71M | 3.54M | 980.64K | 980.64K | 919.14K | 638.34K | 622.86K | 418.52K | 275.33K | 197.22K | 117.42K | 103.11K | 89.77K | 89.66K | 89.34K | 88.71K | 82.79K | 73.56K |
EPS (Basic) | -14.79 | -14.48 | -15.49 | -4.49 | -28.2 | -41.59 | -64.06 | -247.92 | -431.97 | -385.85 | -344.25 | -146.82 | 274.23 | -44.6 | -283.95 | -451.82 | -683.11 | -390.99 |
EPS (Diluted) | -14.79 | -14.48 | -15.49 | -4.49 | -28.17 | -41.55 | -64.02 | -247.21 | -431.07 | -385.02 | -343.42 | -146.69 | 149.73 | -166.32 | -403.98 | -571.56 | -678.29 | -389.07 |
EBITDA | -9.47M | -7.7M | -6.35M | -2.99M | -14.75M | -18.43M | -22.13M | -43.58M | -52.48M | -45.86M | -39.53M | -15.82M | 23.99M | -2.4M | -20.05M | -23.5M | -42.54M | -18.65M |
EBIT | -9.48M | -7.73M | -6.41M | -3.07M | -14.85M | -18.54M | -22.24M | -43.7M | -52.58M | -45.96M | -39.64M | -15.92M | 23.87M | -2.51M | -20.16M | -23.62M | -42.66M | -18.77M |
Depreciation & Amortization | 25.29K | 49.27K | 58.28K | 84.07K | 102.91K | 107.48K | 105.67K | 120.62K | 95.9K | 104.31K | 109K | 94.55K | 121.53K | 114.09K | 116.3K | 124.99K | 121.22K | 121.71K |